Latest 30 News in the Life Sciences Industry
PR Newswire Association LLC.
triSure NIPT Debuts in Taiwan, Expanding Non-Invasive Prenatal Screening Beyond Aneuploidy
14 Apr 2026
PR Newswire Association LLC.
GlycoNex Receives PMDA Approval in Japan to Initiate First-in-Human Phase 1 Trial of GNX1021 in Gastrointestinal Cancers
14 Apr 2026
PR Newswire Association LLC.
NUHS CHARTS NEW ERA OF PERSONALISED CARE WITH GENOMICS AND DATA-GUIDED BREAKTHROUGHS
02 Apr 2026
PR Newswire Association LLC.
Locus Cell, Taiwan-Based Cell and Gene Therapy CDMO, Signs MoU with Charles River at APAC Biomanufacturing Leadership Summit
12 Mar 2026
PR Newswire Association LLC.
LT3001 DEMONSTRATES FUNCTIONAL IMPROVEMENTS IN PATIENTS WITH DISABLING ACUTE ISCHEMIC STROKE
06 Feb 2026
PR Newswire Association LLC.
CMUH-Ever Supreme Team Develops World-First Brain-Targeting Exosome Delivering Curcumin Across the Blood-Brain Barrier for Parkinson's Disease
28 Jan 2026
PR Newswire Association LLC.
NUH INAUGURATES NEW CENTRE TO ADVANCE PREDICTIVE AND ACCESSIBLE CARE FOR DIGESTIVE HEALTH
16 Jan 2026
PR Newswire Association LLC.
Caliway Biopharmaceuticals Presents Preclinical Research Supporting a Multi-Mechanism Approach to Weight Management at TMASO 2025
16 Dec 2025
PR Newswire Association LLC.
Alma Announces Leadership Transition; Lior Dayan Appointed Chairman of Sisram Medical Following Eight Years of Successful Leadership as CEO
09 Dec 2025
PR Newswire Association LLC.
GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy
09 Dec 2025
PR Newswire Association LLC.
GlycoNex Signs CDMO Service Agreement with Change Cure to Advance HMGB1-Targeted Antibody Program
08 Dec 2025
GlobeNewswire
Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
09 Apr 2026
GlobeNewswire
AP Biosciences and Tasly Finalize Amended Collaboration Agreement to Support Global Out-Licensing of AP505 (B1962)
30 Mar 2026
GlobeNewswire
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
29 Mar 2026
GlobeNewswire
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
27 Mar 2026
GlobeNewswire
Novartis presents new data on early symptom relief and long-term control in complex skin diseases at AAD 2026
23 Mar 2026
GlobeNewswire
Novartis agrees to acquire a pan-mutant-selective PI3Kα inhibitor, strengthening its breast cancer pipeline
20 Mar 2026
GlobeNewswire
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
13 Mar 2026
GlobeNewswire
Novartis shareholders approve all resolutions proposed by the Board of Directors at the 2026 Annual General Meeting
06 Mar 2026
GlobeNewswire
Quanta Therapeutics Presents Preclinical Data Establishing that Direct Multi-KRAS Inhibitors Retain Strong Activity Against Resistance Mechanisms Acquired from Treatment with pan-RAS Tri-Complex Inhibitors
05 Mar 2026
GlobeNewswire
Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
27 Feb 2026
GlobeNewswire
Novartis receives positive CHMP opinion for remibrutinib in chronic spontaneous urticaria (CSU)
27 Feb 2026
GlobeNewswire
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
25 Feb 2026
GlobeNewswire
Nu-Tek BioSciences to Highlight Animal-Origin-Free Peptones, Supply Chain Strength at DCAT Week 2026
24 Feb 2026
Latest News All News
Upcoming Events All Events
- April 2026
- Seattle: Life Science Innovation Northwest 2026
- Leipzig: German Biotech Days
- Shanghai: ChinaBio® Partnering Forum